Medical device and technology company Lazurite Holdings LLC has been recognized by MedTech Outlook magazine as a 2021 Top 10…
Browsing: Hot headlines in GI
Results from a double-blind, randomized OPT-PEACE trial showed that almost all patients (at low bleeding risk) who received antiplatelet therapy…
According to the hospital, the most effective treatment for metastatic colorectal cancer is targeted therapy and chemotherapy, which block only…
By Landon Gray Originally published in our sister publication, Gastroenterology & Endoscopy News Phathom announced the FDA approval of vonoprazan tablets, amoxicillin capsules, clarithromycin tablets (Voquezna Triple PAK, Phathom)…
A complaint filed with the U.S. Department of Justice (DOJ) alleges that Alabama’s Medicaid program is illegally denying curative drug…
Applications are now open for the 2023 AGA Fellowship cohort. AGA is proud to formally recognize its exemplary members whose accomplishments and contributions…
ISFIYA, Israel, May 11, 2022 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of…
The GI Research Foundation, an established non-profit dedicated to raising funds to advance the science and treatment of digestive diseases,…
Three years after a spinoff from Takeda, Phathom Pharmaceuticals has successfully crossed the FDA finish line with a drug it got from…
The encouraging uptick in screening rates for colorectal cancer came to a halt with the emergence of SARS-CoV-2 and COVID-19.…